Drug Utilization Evaluation of Anti-Diabetic Medication through Prescription Monitoring
DOI:
https://doi.org/10.22270/ajprd.v7i3.537Keywords:
Diabètes, Prescription, Drug Utilization, Distribution, Patients.Abstract
Diabetes is a chronic and potentially disabling disease that represents an important public health and clinical concern. The study was designed to assess the drug utilization evaluation of anti-diabetic medications through prescription monitoring in a tertiary care hospital at capital city Dehradun in a northern state Uttarakhand. Prescriptions from patients of diabetes were selected for the study and data was collected from patients using a questionnaire format. All the necessary and relevant information will be collected from out-patient prescriptions, laboratory data reports and also by verbal communication with patients. Out of total 100 prescriptions of diabetic patients, it was found that gender wise distribution of diabetic patients was more in females (64%) as compared to males (36%). Among 100 patients, type 1 diabetes occurred in 16% patients and type 2 diabetes occurred in 84% patients. It was also analyzed that both type 1 and type 2 diabetes were mostly occurred in females. Among type 2 diabetes patients, Glimepiride were mostly prescribed in 42% patients, followed by Metformin in 22% patients and Gliclazide in 20% while in type 1 diabetes patients, Human Insulin were prescribed in 16% patients. Prescription analysis showed that maximum prescriptions (50%) contain two drugs per prescription while six drugs per prescription were shown by only 2% prescriptions. This study may provide further help to prescribers for improvement in current prescribing trends in the management of diabetes mellitus.
Downloads
References
2. WHO Expert Committee. The Selection of Essential Drug, Technical Report Series No. 615. Geneva: World Health
Organization, 1977.
3. Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: a pathophysiologic approach.
Sixth edition pp no. 1333-1367.
4. Joshi Y, Pant R, Mittal P, Juyal V, Agrawal AC. Prevalence of Diabetes Mellitus in Patient Population of Dehradun.
The Pharma Review. 2008; 6(33):168-170.
5. Joshi Y, Pant R, Rawat M. Evaluation of Drug Utilization Pattern of Antidiabetic Drugs among Patients of
Dehradun. The Indian Pharmacis. 2008; 7(72):65-70.
6. Adhikari AK, Vidyasagar G, Rathore DS, Balaram G, Bhakti G. A drug utilisation review on antidiabetic drugs in a
tertiary care hospital of india, Indian journal of hospital pharmacy 2011
7. Maniyar Y, Bhixavatimath P, Akkone V. A Drug Utilization Study in the Ophthalmology Department of a
Medical College, Karnataka, India. Journal of Clinical and Diagnostic Research. 2011; 5(1):82-84.
8. Holloway K, Green T. Drug and therapeutics committees - A practical guide. Geneva: World Health Organization.
2003; 71-94.
9. Meigs JB, Cupples LA, Wilson PW. Parentral Transmission of Type 2 Diabetes: The Framingham Offspring Study.
Diabetes care 2000; 49: 2201-2207.
10. American Diabetes Association. Standards of Medical Care in Diabetes - 2015. Diabetes Care. 2015; 38(1):S33-
S40.
11. Rodbard HW, Blonde L, Braithwaite SS. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force.
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Management of
Diabetes Mellitus. Endocr Pract. 2007; 13(1):1-68.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.